BTI
GNOM icon

Blue Trust Inc’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Blue Trust Inc’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-88
Closed -$3.42K – 2616
2025
Q3 		$3.42K Buy
+88
New +$3.19K ﹤0.01% 2064

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Blue Trust Inc's GNOM Position: Q4 2025 in Review

Blue Trust Inc sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2025, closing a stake of 88 shares — an estimated $3.42K sold.

Blue Trust Inc first reported a position in GNOM in Q3 2025 and held it in 1 quarter. The position peaked at $3.42K in Q3 2025. 40 funds tracked by Wall St. Rank hold GNOM as of Q4 2025.

  • Blue Trust Inc reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
  • Blue Trust Inc sold 88 Global X Genomics & Biotechnology ETF shares in Q4 2025, an estimated $3.42K.
  • Blue Trust Inc first reported a position in Global X Genomics & Biotechnology ETF in Q3 2025 and held it in 1 quarter.
  • Blue Trust Inc's Global X Genomics & Biotechnology ETF position peaked at $3.42K in Q3 2025.
  • 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2025.

Based on Blue Trust Inc's 13F filing for Q4 2025, filed 16 Jan 2026.